drugset / Trial / NCT02098239
Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.
Non-randomizedOpen-labelTreatment
Summary
The study was designed to assess the effect of jaundice on the ability of G17DT to generate antibodies before and after treatment of biliary obstruction due to advances pancreatic cancer.
Timeline
- Start
- 1999-08
- Primary completion
- 2002-04
- Completion
- 2002-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | G17DT Immunogen | Vaccine | — | Intramuscular |